Halozyme Therapeutics, Inc.HALONASDAQ
LOADING
|||
Switch Symbol:
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$468.37M
↑ 254% above average
Average (9y)
$132.40M
Historical baseline
Range
High:$468.37M
Low:$-89.46M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $468.37M | +25.5% |
| 2023 | $373.28M | +58.6% |
| 2022 | $235.30M | -21.0% |
| 2021 | $297.98M | +462.8% |
| 2020 | $52.95M | +159.2% |
| 2019 | $-89.46M | -65.2% |
| 2018 | $-54.16M | -140.8% |
| 2017 | $132.70M | +348.0% |
| 2016 | $-53.52M | -35.7% |
| 2015 | $-39.44M | - |